This research study is studying an investigational drug as a possible treatment for breast
cancer that is positive for the protein Human Epidermal Growth Factor Receptor 2, also known
as HER2-positive breast cancer.
The drug involved in this study is:
-ado-trastuzumab emtansine (T-DM1)
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Gateway for Cancer Research Susan G. Komen Breast Cancer Foundation